Risk factors associated with acute hip prosthetic joint infections and outcome of treatment with a rifampin-based regimen

Acta Orthop. 2008 Jun;79(3):455-6; author reply 456-7. doi: 10.1080/17453670710015418.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Acute Disease
  • Antibiotics, Antitubercular / therapeutic use*
  • Arthroplasty, Replacement, Hip / adverse effects*
  • Humans
  • Prosthesis-Related Infections / drug therapy*
  • Prosthesis-Related Infections / microbiology
  • Prosthesis-Related Infections / prevention & control
  • Rifampin / therapeutic use*
  • Risk Factors
  • Treatment Outcome

Substances

  • Antibiotics, Antitubercular
  • Rifampin